Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Day Zero Diagnostics Announces Completion of $21M Financing
Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing […]
Healx and Ovid Therapeutics Enter Strategic Partnership
Ovid Therapeutics (NASDAQ:OVID) (“Ovid”), a biopharmaceutical company committed to developing medicines that transform the lives of […]
NHS Publishes Electives Recovery Plan To Boost Capacity And Give Power To Patients
The NHS and government have today set out a blueprint to address backlogs built up during the Covid […]
Oncode Institute and ArgoBio Launch Laigo Bio, a Targeted Protein Degradation Biotech with Programs in Oncology and Neurological Disorders
ArgoBio and Oncode Institute have teamed up with Oncode Investigator Madelon Maurice, researcher and group leader at UMC Utrecht, to launch […]
Enterprise Therapeutics Appoints Dr Niyati Prasad as Chief Medical Officer
Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel […]
Machine Learning Voice Tool Trialled to Help Manage Depression
Green Door Clinic – a specialist mental health clinic based in the Harley Street Medical […]
Pfizer and Alex Therapeutics Announce a Strategic Commercial Partnership to Provide Evidence-based Digital Therapeutics to Patients, Starting in Germany
The Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics and world leading pharmaceutical company Pfizer have joined […]
Antiverse Collaborates with a Top 20 Pharma Company to Identify Antibody Drug Candidates Using AI Augmented Drug Discovery Platform
Antiverse, a biotechnology company developing a computational antibody drug discovery platform, today announced a partnership […]
Tollys Accelerates Development of TLR3 Agonist Candidates for Intravenous Administration in Immuno-oncology
Tollys, a biopharmaceutical company developing the first anti-cancer immunotherapy based on a synthetic Toll-Like Receptor […]
PrecisionLife Announces First Close of Series A Financing to Progress its Drug Discovery Pipeline and Commercial Partnerships
PrecisionLife Limited, a global techbio company driving precision medicine in chronic disease with AI-led drug […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more